Use of the Dietary Supplement 5-Aminiolevulinic Acid (5-ALA) and Its Relationship with Glucose Levels and Hemoglobin A1C among Individuals with Prediabetes

Clinical and Translational Science

Volumn 5, Issue 4, 2012, Pages 314-320

  Rodriguez, Beatriz L ^a   Curb, J David ^a   Davis, James ^a   Shintani, Terry ^a   Perez, Michael H ^a   Apau Ludlum, Noelani ^a   Johnson, Crystal ^a   Harrigan, Rosanne C ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Diabetes; Diabetes mellitus; Glucose; Metabolism

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOLEVULINIC ACID; ASPARTATE TRANSFER RNA LIGASE; CREATININE; FERRITIN; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT RESPONSE;

ADULT; AGED; AMINOLEVULINIC ACID; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 84864947668     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2012.00421.x     Document Type: Article

References (25)

1. Willows RD. Chlorophylls. In: Goodman RM, ed. Encyclopaedia of Plant and Crop Science. London: Taylor & Francis Group, 2004: 258-262.
2. Hua MD, HC. Study on the Safety of Oral ALA Phosphate in Healthy Adults (3). Protocol No.: 21570. Date submitted: June 11, 2010. Submitted by: SBI ALApromo Co.Ltd. Study site: Meguro Medical Clinic, Medical4 Corporation Yukokai Research Organization: TTC Co. Ltd., Tokyo (Representing Director: Tetsuro Yamamoto, Ph.D.).
3. Beale SI. Biosynthesis of the tetrapyrrole pigment precursor, 5-aminolevulinic acid, from glutamate. Plant Physiol. 1990; 93(4): 1273-1279.
4. Waget A., Cabou C, Masseboeuf M, Cattan P, Armanet M, Karaca M, Castel J, Garret C, Payros G, Maida A, et al. Diabetes-insulin-glucagon-gastrointestinal: physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice. Endocrinology. 2011; 152(8): 3018-3029.
5. Fotinos N, Campo MA, Popowycz F, Gurny R, Lange N. Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol. 2006Jul-Aug; 82(4): 994-1015.
6. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Jūrgen Reulen H. Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000Dec; 93(6): 1003-1013.
7. Ladner DP, Steiner RA, Allemann J, Haller U, Walt H. Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid. Br J Breast Cancer. 2001; 84(1): 33-37.
8. Sugawara K, Ishiuchi S, Kurihara H, Nakazato Y, Saito N. Intraoperative fluorescence detection of malignant gliomas using 5-Aminolevulinic acid. Kitakanto Med J. 2003; 53(2): 109-113.
9. Webber J, Kessel, D, Fromm, D. Side effects of photosensitization of human tissue after aminolevulinic acid. J Surg Res. 1977; 68: 31-37.
10. Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue B, Finkelstein D, Hasan T. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res. 2010; 70: 9319-9328. doi:10.1158/0008-5472.CAN-10-1783.
11. Tope WD, Ross V, Kollias N, Martin A, Gillies R, Anderson RR. Protoporphyrin IX induced in basel cell carcinoma by 5 aminolevulinic acid. Photochem Photobiol. 1998; 67(2): 249-255.
12. Ganzer, Blana A, Denzinger S, Wieland WF, Adam C, Becker A, Khoder W, Walther S, Stief CG, Zaak D, et al. Intraoperative photodynamic evaluation of surgical margins during endoscopic extraperitoneal radical prostatectomy with the use of 5-aminolevulinic acid. J Endourol. 2009; 23(9) 1387-1394.
13. Zaak, Sroka R, Khoder W, Adam C, Tritschler S, Karl A, Reich O, Knuechel R, Baumgartner R, Tilki D. Photodynamic diagnosis of prostate cancer using 5-Aminolevulinic acid-first clinical experiences. J Urology. 2008; 72(2): 345-348. doi:10.1016.
14. Ogura S, Maruyama K, Hagiya Y, Sugiyama Y, Tsuchiya K, Takahashi K, Abe F, Tabata K, Okura I, Nakajima M, et al. The effect of 5-Aminolevulinic acid on cytochrome coxidase activity in mouse liver. BMC Res Notes. 2011; 4: 66.
15. Morton KA, Kushner P, Straka JG, Burnham BF. Biosynthesis of 5-Aminolevulinic acid and heme from 4, 5-dioxovalerate in the rat. J Clin Invest. 1983June; 71(6): 1744-1749.
16. Ritz R, Feigl GC, Schuhmann MU, Ehrhardt A, Danz S, Noell S, Bornemann A, Tatagiba MS. Use of 5-ALA fluorescence guided endoscopic biopsy of a deep-seated primary malignant brain tumor. J Neurosurg. 2011May; 114(5): 1410-1413.
17. Ji HT, Chien LT, Lin YH, Chien HF, Chen CT. 5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase. Mol Cancer. 2010; Apr 28; 9: 91.
18. Rodriguez BL, Curb JD, Burchfiel CM, Abbott RD, Petrovitch H, Masaki K, Chiu D. Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle aged men. The Honolulu Heart program. Circulation. 1994; 89(6): 2540-2544.
19. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Social Behav. 1983; 24: 386-396.
20. SAS Institute Inc. SAS/STAT® 9.2 User's Guide. Cary, NC: SAS Institute Inc.; 2008.
21. Rodriguez BL, Abbott RD, Fujimoto W, Waitzfelder B, Chen R, Masaki K, Schatz I, Petrovitch H, Ross GW, Yano K, et al. The American Diabetes Association and World Health Organization Classifications for Diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. Diabetes Care. 2002; 25: 951-955.
22. Rodriguez BL, Burchfiel CM, Huang B, Sharp DS, Yano K, Lu J, Fujimoto W. Impaired glucose tolerance, diabetes and cardiovascular risk factor profiles in the elderly; the Honolulu Heart Program. Diabetes Care. 1996; 19: 587-590.
23. Curb JD, Rodriguez BL, Burchfiel C, Yano K, Chiu D. Sudden death, glucose intolerance and diabetes in Japanese-American men. Circulation. 1995; 91: 2591-2595.
24. Burchfiel C, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence; the Honolulu Heart Program. Stroke. 1994; 25: 951-957.
25. Djordjević V. Delta-aminolevulinic acid dehydratase activity in erythrocytes of diabetic patients. Arch Int Physiol Biochim. 1985Nov; 93(4): 285-290.